Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	182	237	158	308	51	13
Market Cap Growth	10.58%	49.79%	-48.52%	505.80%	302.97%	-73.24%
Enterprise Value	174	213	90	197	117	89
PE Ratio	-	-5.15	-5.92	-4.89	-3.98	-0.51
PS Ratio	6.52	8.64	15.59	10.74	3.82	0.98
PB Ratio	3.74	3.84	2.11	2.42	-0.76	-0.17
P/FCF Ratio	-4.57	-7.01	-8.42	29.76	-25.75	-0.53
P/OCF Ratio	-4.60	-7.07	-8.46	29.47	-26.19	-0.53
EV/Sales Ratio	6.21	7.77	8.82	6.87	8.79	6.90
EV/EBITDA Ratio	-4.35	-4.90	-3.51	-24.49	-15.10	-4.57
EV/EBIT Ratio	-4.13	-4.79	-3.39	-23.73	-14.59	-4.50
EV/FCF Ratio	-4.39	-6.30	-4.77	19.05	-59.24	-3.73
Debt / Equity Ratio	0.91	0.71	0.19	0.01	-1.06	-1.07
Debt / EBITDA Ratio	-0.96	-1.01	-0.55	-0.20	-9.09	-4.10
Debt / FCF Ratio	-0.96	-1.29	-0.75	0.15	-35.68	-3.35
Quick Ratio	2.04	1.15	7.58	26.92	0.92	1.00
Current Ratio	2.10	1.18	7.72	27.20	1.11	1.28
Asset Turnover	0.20	0.21	0.08	0.23	1.22	0.91
Interest Coverage	-23.77	-29.68	-79.01	-36.70	-1.67	-4.05
Return on Equity (ROE)	-82.60%	-68.40%	-27.50%	-53.10%	19.60%	32.50%
Return on Assets (ROA)	-35.80%	-35.20%	-22.10%	-50.40%	-117.00%	-174.30%
Return on Capital (ROIC)	-61.40%	-46.96%	-47.70%	6.01%	-142.32%	-400.97%
Earnings Yield	-27.90%	-19.41%	-16.90%	-20.45%	-25.13%	-194.59%
FCF Yield	-25.17%	-14.26%	-11.88%	3.36%	-3.88%	-188.57%
Buyback Yield / Dilution	-21.22%	-2.79%	-15.87%	-647.71%	-114.79%	-65.39%
Total Shareholder Return	-21.22%	-2.79%	-15.87%	-647.71%	-114.79%	-65.39%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).